Mechanisms of Inflammatory Liver Injury and Drug-Induced Hepatotoxicity

被引:68
|
作者
Woolbright B.L. [1 ]
Jaeschke H. [2 ]
机构
[1] Department of Urology, University of Kansas Medical Center, Kansas City, 66160, KS
[2] Department of Pharmacology, Toxicology & Therapeutics, University of Kansas Medical Center, 3901 Rainbow Blvd, MS 1018, Kansas City, 66160, KS
基金
美国国家卫生研究院;
关键词
Acetaminophen; Adaptive immunity; Drug-induced liver injury; Innate immunity; Monocytes; Neutrophils; Reactive metabolites;
D O I
10.1007/s40495-018-0147-0
中图分类号
学科分类号
摘要
Purpose of Review: This article provides a brief overview of mechanisms of inflammatory liver injury and how this applies to drug hepatotoxicity with a particular emphasis on the role of inflammation in acetaminophen-induced liver injury. Recent Findings: Significant progress has been made in the last decade in our understanding of the initiation of sterile inflammation after necrotic cell death by the release of damage-associated molecular patterns and their recognition by toll-like receptors and others on macrophages. These events trigger the formation of cytokines and chemokines directly or with assistance of inflammasome activation thereby activating and recruiting leukocytes including neutrophils and monocyte-derived macrophages into the necrotic areas. Although this sterile inflammatory response is mainly geared towards the removal of necrotic cell debris and preparation of regeneration, there are conditions where these innate immune cells can aggravate the initial injury. The mechanisms and controversial findings of the innate immunity are being discussed in detail. In contrast, drug metabolism and formation of a reactive metabolite that binds to proteins in the absence of extensive cell death can induce an adaptive immune response, which eventually also results in severe liver injury. However, the initiating event appears to be the formation of protein adducts, which act as haptens to activate an adaptive immune response. Overall, these mechanisms are less well understood. Summary: The past decade has revolutionized our understanding of the mechanisms that control the interplay between cell death and innate or adaptive immune responses. This report provides an update on these mechanisms. © 2018, Springer International Publishing AG, part of Springer Nature.
引用
收藏
页码:346 / 357
页数:11
相关论文
共 50 条
  • [21] Mitochondrial Dynamics in Drug-Induced Liver Injury
    Ramachandran, Anup
    Umbaugh, David S.
    Jaeschke, Hartmut
    LIVERS, 2021, 1 (03): : 102 - 115
  • [22] Immunological aspects of drug-induced liver injury
    Kazuto Tajiri
    Yukihiro Shimizu
    World Journal of Immunology, 2014, 4 (03) : 149 - 157
  • [23] Models of Idiosyncratic Drug-Induced Liver Injury
    Yokoi, Tsuyoshi
    Oda, Shingo
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 61, 2021, 2021, 61 : 247 - 268
  • [24] Drug-Induced Liver Injury and Drug Development: Industry Perspective
    Regev, Arie
    SEMINARS IN LIVER DISEASE, 2014, 34 (02) : 227 - 239
  • [25] Drug-induced liver injury in pregnancy
    Lao, Terence T.
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2020, 68 : 32 - 43
  • [26] Drug-induced liver injury in children
    Amin, Mansi D.
    Harpavat, Sanjiv
    Leung, Daniel H.
    CURRENT OPINION IN PEDIATRICS, 2015, 27 (05) : 625 - 633
  • [27] Drug-induced liver injury in the elderly
    Stine J.G.
    Sateesh P.
    Lewis J.H.
    Current Gastroenterology Reports, 2013, 15 (1)
  • [28] Drug-induced liver injury in 2007
    Norris, William
    Paredes, Angelo H.
    Lewis, James H.
    CURRENT OPINION IN GASTROENTEROLOGY, 2008, 24 (03) : 287 - 297
  • [29] Biomarkers for drug-induced liver injury
    Shi, Qiang
    Hong, Huixiao
    Senior, John
    Tong, Weida
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2010, 4 (02) : 225 - 234
  • [30] Signatures in drug-induced liver injury
    Tillmann, Hans L.
    Rockey, Don C.
    CURRENT OPINION IN GASTROENTEROLOGY, 2020, 36 (03) : 199 - 205